Acro Biomedical Co Ltd ACBM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.11
- Day Range
- $0.11–0.11
- 52-Week Range
- $0.11–4.50
- Bid/Ask
- $0.01 / $2.00
- Market Cap
- $6.30 Mil
- Volume/Avg
- 300 / 5,159
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 17.51
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Acro Biomedical Co Ltd develops and manufactures nutritional products. The company offers cordyceps fungus for medicinal purposes. It also sells cordycepin and cordyceps powder.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- —
- Total Number of Employees
- 1
- Website
- http://www.acrobiomedical.com
Comparables
Valuation
Metric
|
ACBM
|
VSBC
|
SCLX
|
---|---|---|---|
Price/Earnings (Normalized) | — | 3,629.76 | — |
Price/Book Value | 4.67 | 1,908.62 | — |
Price/Sales | 17.51 | 664.53 | 2.65 |
Price/Cash Flow | — | 2,904.34 | — |
Price/Earnings
ACBM
VSBC
SCLX
Financial Strength
Metric
|
ACBM
|
VSBC
|
SCLX
|
---|---|---|---|
Quick Ratio | 2.51 | 4.32 | 0.15 |
Current Ratio | 2.64 | 4.33 | 0.19 |
Interest Coverage | −5,289.20 | — | −106.04 |
Quick Ratio
ACBM
VSBC
SCLX
Profitability
Metric
|
ACBM
|
VSBC
|
SCLX
|
---|---|---|---|
Return on Assets (Normalized) | −37.24% | 42.38% | −106.47% |
Return on Equity (Normalized) | −2.74% | 65.38% | — |
Return on Invested Capital (Normalized) | −48.36% | 55.23% | −1,960.39% |
Return on Assets
ACBM
VSBC
SCLX
Medical Distribution Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
MCK
| McKesson Corp | Zktdkcjk | Hjpbdhk | $69.0 Bil | |
COR
| Cencora Inc | Klrrftlm | Bstzhh | $47.2 Bil | |
CAH
| Cardinal Health Inc | Krldwsntl | Qtglql | $26.3 Bil | |
SHPMY
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H | — | Nzvxwmk | $8.2 Bil | |
SHPMF
| Shanghai Pharmaceuticals Holding Co Ltd Class H | — | Kwznsxl | $8.0 Bil | |
SHTDY
| Sinopharm Group Co Ltd ADR | — | Tyjwfq | $7.9 Bil | |
SHTDF
| Sinopharm Group Co Ltd | — | Nnvsn | $7.9 Bil | |
AMFPF
| Amplifon SpA Az nom Post Frazionamento | — | Njtycbs | $7.6 Bil | |
MAHLY
| Medipal Holdings Corp ADR | — | Wpqz | $3.3 Bil | |
MEPDF
| Medipal Holdings Corp | — | Pqmv | $3.2 Bil |